Statistical Considerations for Clinical Trials in Developing Antimicrobial Drugs

Anti-infective Drug Products

Advisory Committee

July 29, 1998

Daphne Lin, Ph.D.

CDER/OEB/DBIV

Next slide

Back to first slide

View graphic version